Citations (69)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Clara M. Castillejo Becerra, Cynthia S. Crowson, Matthew J. Koster, Kenneth J. Warrington, M. Tariq Bhatti & John J. Chen. (2022) Population-based Rate and Patterns of Diplopia in Giant Cell Arteritis. Neuro-Ophthalmology 46:2, pages 75-79.
Read now
Read now
David F. Skanchy, Aroucha Vickers, Claudia M. Prospero Ponce & Andrew G. Lee. (2019) Ocular manifestations of giant cell arteritis. Expert Review of Ophthalmology 14:1, pages 23-32.
Read now
Read now
Edsel B Ing, Royce Ing, Xinyang Liu, Angela Zhang, Nurhan Torun, Michael Sey & Christian Pagnoux. (2018) Does herpes zoster predispose to giant cell arteritis: a geo-epidemiologic study. Clinical Ophthalmology 12, pages 113-118.
Read now
Read now
Articles from other publishers (66)
Edward J. Bilton & Susan P. Mollan. (2023) Giant cell arteritis: reviewing the advancing diagnostics and management. Eye 37:12, pages 2365-2373.
Crossref
Crossref
Konstanze V. Guggenberger, Athanasios Pavlou, Quy Cao, Ishaan J. Bhatt, Qi N. Cui, Thorsten A. Bley, Hugh D. Curtin, Julien Savatovsky & Jae W. Song. (2023) Orbital magnetic resonance imaging of giant cell arteritis with ocular manifestations: a systematic review and individual participant data meta-analysis. European Radiology 33:11, pages 7913-7922.
Crossref
Crossref
Christopher Hino, Ehizogie Edigin, Osaigbokan Aihie, Jesse Odion, Precious Eseaton, Victory Okpujie, Precious Onobraigho, Eugene Omoike, Augustine Manadan & Mehrnaz Hojjati. (2023) Longitudinal Trends of Hospitalizations for Giant Cell Arteritis: A 21-Year Longitudinal National Population-Based Study. Cureus.
Crossref
Crossref
Solange Gonzalez Chiappe, Sarah Lechtman, Carla Soledad Maldini, Arsène Mekinian, Thomas Papo, Thomas Sené & Alfred Daniel Mahr. (2022) Incidence of giant cell arteritis in six districts of Paris, France (2015–2017). Rheumatology International 42:10, pages 1721-1728.
Crossref
Crossref
Despina Michailidou, Tianyu Zhang, Pavlos Stamatis & Bernard Ng. (2022) Risk of venous and arterial thromboembolism in patients with giant cell arteritis and/or polymyalgia rheumatica: A Veterans Health Administration population‐based study in the United States. Journal of Internal Medicine 291:5, pages 665-675.
Crossref
Crossref
Jaume Mestre-Torres, Fernando Martínez-Valle, Alejandra Gabaldón, Marc Simó-PerdigóM. Teresa Salcedo-Allende, Ignacio Navales-Mateu & Roser Solans-Laqué. (2022) Are Temporal Artery Biopsy Findings Related to PET/CT Findings in Giant Cell Arteritis?. Clinical Nuclear Medicine 47:5, pages 387-393.
Crossref
Crossref
Erin Yu & Jessica R. Chang. (2022) Giant Cell Arteritis: Updates and Controversies. Frontiers in Ophthalmology 2.
Crossref
Crossref
Milena Bond, Alessandro Tomelleri, Frank Buttgereit, Eric L. Matteson & Christian Dejaco. (2022) Looking ahead: giant-cell arteritis in 10 years time. Therapeutic Advances in Musculoskeletal Disease 14, pages 1759720X2210963.
Crossref
Crossref
Pavlos Stamatis, Aleksandra Turkiewicz, Martin Englund, Carl Turesson & Aladdin J Mohammad. (2022) Epidemiology of biopsy-confirmed giant cell arteritis in southern Sweden—an update on incidence and first prevalence estimate. Rheumatology 61:1, pages 146-153.
Crossref
Crossref
Thomas D. Garvey, Matthew J. Koster, Cynthia S. Crowson & Kenneth J. Warrington. (2021) Incidence, survival, and diagnostic trends in GCA across seven decades in a North American population-based cohort. Seminars in Arthritis and Rheumatism 51:6, pages 1193-1199.
Crossref
Crossref
Pavlos Stamatis, Aleksandra Turkiewicz, Martin Englund, Carl Turesson & Aladdin J Mohammad. (2021) Comment on: Epidemiology of biopsy-confirmed giant cell arteritis in southern Sweden—an update on incidence and first prevalence estimate: reply. Rheumatology 60:11, pages e423-e424.
Crossref
Crossref
Tomás Urrego-Callejas, Daniel Jaramillo-Arroyave, Adriana-Lucía Vanegas-García, Carlos Horacio Muñoz-Vahos & Maribel Plaza Tenorio. (2021) Temporal artery Doppler ultrasound in patients with giant cell arteritis: State of the art and systematic review of the literature. Revista Colombiana de Reumatología (English Edition) 28:3, pages 203-212.
Crossref
Crossref
Tomás Urrego-Callejas, Daniel Jaramillo-Arroyave, Adriana-Lucía Vanegas-García, Carlos Horacio Muñoz-Vahos & Maribel Plaza Tenorio. (2021) Ultrasonido Doppler de arterias temporales en pacientes con arteritis de células gigantes: estado del arte y revisión sistemática de la literatura. Revista Colombiana de Reumatología 28:3, pages 203-212.
Crossref
Crossref
Sang-Wan Chung. (2021) Vasculitis: From Target Molecules to Novel Therapeutic Approaches. Biomedicines 9:7, pages 757.
Crossref
Crossref
Thomas D. Garvey, Matthew J. Koster & Kenneth J. Warrington. (2021) My Treatment Approach to Giant Cell Arteritis. Mayo Clinic Proceedings 96:6, pages 1530-1545.
Crossref
Crossref
Kisaki Amemiya, Hatsue Ishibashi-Ueda, Elie Mousseaux, Paul Achouh, Masahiko Ochiai & Patrick Bruneval. (2021) Comparison of the damage to aorta wall in aortitis versus noninflammatory degenerative aortic diseases. Cardiovascular Pathology 52, pages 107329.
Crossref
Crossref
Alicia Rodriguez-Pla & Jose Rossello-Urgell. (2021) Trend and Geographic Disparities in the Mortality Rates of Primary Systemic Vasculitis in the United States from 1999 to 2019: A Population-Based Study. Journal of Clinical Medicine 10:8, pages 1759.
Crossref
Crossref
Philip Therkildsen, Annette de Thurah, Ib Tønder Hansen, Mette Nørgaard, Berit Dalsgaard Nielsen & Ellen-Margrethe Hauge. (2021) Giant cell arteritis: A nationwide, population-based cohort study on incidence, diagnostic imaging, and glucocorticoid treatment. Seminars in Arthritis and Rheumatism 51:2, pages 360-366.
Crossref
Crossref
Sumu Simon, Jem Ninan & Pravin Hissaria. (2021) Diagnosis and management of giant cell arteritis: Major review. Clinical & Experimental Ophthalmology 49:2, pages 169-185.
Crossref
Crossref
Jintana B. Andersen, Geirmund Myklebust, Glenn Haugeberg, Are H. Pripp & Andreas P. Diamantopoulos. (2021) Incidence Trends and Mortality of Giant Cell Arteritis in Southern Norway. Arthritis Care & Research 73:3, pages 409-414.
Crossref
Crossref
Pavlos Stamatis, Aleksandra Turkiewicz, Martin Englund, Göran Jönsson, Jan-Åke Nilsson, Carl Turesson & Aladdin J Mohammad. (2021) Infections Are Associated With Increased Risk of Giant Cell Arteritis: A Population-based Case-control Study from Southern Sweden. The Journal of Rheumatology 48:2, pages 251-257.
Crossref
Crossref
Megha Kaushik, Cristina Ponte & Susan P. Mollan. (2021) Current advances in giant cell arteritis. Current Opinion in Neurology 34:1, pages 133-141.
Crossref
Crossref
Delamo I. Bekele, Kenneth J. Warrington & Matthew J. Koster. (2020) Giant cell arteritis associated with inflammatory bowel disease: a case-series and review of the literature. Rheumatology International 41:2, pages 487-492.
Crossref
Crossref
Donatienne de Mornac, Olivier Espitia, Antoine Néel, Jérôme Connault, Agathe Masseau, Alexandra Espitia-Thibault, Mathieu Artifoni, Aurélie Achille, Anaïs Wahbi, Mathieu Lacou, Cécile Durant, Pierre Pottier, François Perrin, Julie Graveleau, Mohamed Hamidou, Jean-Benoit Hardouin & Christian Agard. (2021) Large-vessel involvement is predictive of multiple relapses in giant cell arteritis. Therapeutic Advances in Musculoskeletal Disease 13, pages 1759720X2110090.
Crossref
Crossref
Salman Bin Mahmood, Yuanyuan Ji, Yi Peng & Zaki Abou Zahr. (2020) Incidence of giant cell arteritis after bisphosphonate exposure: A retrospective cohort study. International Journal of Rheumatic Diseases 24:1, pages 63-68.
Crossref
Crossref
Rebecca L. Manno & Jason E. Liebowitz. 2021. Geriatrics for Specialists. Geriatrics for Specialists
219
238
.
Fabrizio Cantini & Carlotta Nannini. 2021. Large and Medium Size Vessel and Single Organ Vasculitis. Large and Medium Size Vessel and Single Organ Vasculitis
9
20
.
S. P. Mollan, K. Paemeleire, J. Versijpt, R. Luqmani & A. J. Sinclair. (2020) European Headache Federation recommendations for neurologists managing giant cell arteritis. The Journal of Headache and Pain 21:1.
Crossref
Crossref
Fernanda Tavares-Da-Silva, Olivia Mahaux, Lionel Van Holle, François Haguinet, Harry Seifert & Jens-Ulrich Stegmann. (2020) Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Methodology. Drug Safety 43:12, pages 1223-1234.
Crossref
Crossref
Lillian Barra, Janet E Pope, Priscila Pequeno, Farah E Saxena, Mary Bell, Derek Haaland & Jessica Widdifield. (2020) Incidence and prevalence of giant cell arteritis in Ontario, Canada. Rheumatology 59:11, pages 3250-3258.
Crossref
Crossref
Jessica N. Williams, Chandra L. Ford, Michelle Morse & Candace H. Feldman. (2020) Racial Disparities in Rheumatology Through the Lens of Critical Race Theory. Rheumatic Disease Clinics of North America 46:4, pages 605-612.
Crossref
Crossref
Ankita Sharma, Aladdin J. Mohammad & Carl Turesson. (2020) Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: A systematic literature review. Seminars in Arthritis and Rheumatism 50:5, pages 1040-1048.
Crossref
Crossref
Samuel Deshayes, Hubert de Boysson, Anaël Dumont, Denis Vivien, Alain Manrique & Achille Aouba. (2020) An overview of the perspectives on experimental models and new therapeutic targets in giant cell arteritis. Autoimmunity Reviews 19:10, pages 102636.
Crossref
Crossref
Aksel Thuv Nilsen, Christine Karlsen, Gunnstein Bakland, Richard Watts, Raashid Luqmani & Wenche Koldingsnes. (2020) Increasing incidence and prevalence of ANCA-associated vasculitis in Northern Norway. Rheumatology 59:9, pages 2316-2324.
Crossref
Crossref
Julius Matthias Weinrich, Alexander Lenz, Gerhard Adam, Christopher J. François & Peter Bannas. (2020) Radiologic Imaging in Large and Medium Vessel Vasculitis. Radiologic Clinics of North America 58:4, pages 765-779.
Crossref
Crossref
Emma Rubenstein, Carla Maldini, Solange Gonzalez-Chiappe, Sylvie Chevret & Alfred Mahr. (2020) Sensitivity of temporal artery biopsy in the diagnosis of giant cell arteritis: a systematic literature review and meta-analysis. Rheumatology 59:5, pages 1011-1020.
Crossref
Crossref
Quentin Richier, Thylbert Deltombe, Aurélie Foucher, Céline Roussin & Loic Raffray. (2020) Giant cell arteritis incidence in La Reunion island, a particularly cosmopolite region of south hemisphere. European Journal of Internal Medicine 74, pages 119-120.
Crossref
Crossref
Abid Awisat & Raashid Luqmani. 2020. Rheumatic Disease in Geriatrics. Rheumatic Disease in Geriatrics
281
291
.
Devon A. Cohen & John J. Chen. 2020. Neurological Emergencies. Neurological Emergencies
85
105
.
Michael K. Yoon & Joseph F. RizzoIIIIII. (2019) Giant Cell Arteritis in Black Patients. JAMA Ophthalmology 137:10, pages 1180.
Crossref
Crossref
Anna M. Gruener, Ali Poostchi, Andrew R. Carey, Charles G. Eberhart, Amanda D. Henderson, Jessica R. Chang & Timothy J. McCulley. (2019) Association of Giant Cell Arteritis With Race. JAMA Ophthalmology 137:10, pages 1175.
Crossref
Crossref
Jaume Mestre-Torres, Marc Simó-Perdigó, Fernando Martínez-Valle, Ignacio Navales, Jose Loureiro-Amigo & Roser Solans-Laque. (2019) Risk of ischaemic events at giant cell arteritis diagnosis according to PET/CT findings. European Journal of Nuclear Medicine and Molecular Imaging 46:8, pages 1626-1632.
Crossref
Crossref
Alia Z. Al-Mousawi, Sam P. Gurney, Alice R. Lorenzi, Ute Pohl, Margaret Dayan & Susan P. Mollan. (2019) Reviewing the Pathophysiology Behind the Advances in the Management of Giant Cell Arteritis. Ophthalmology and Therapy 8:2, pages 177-193.
Crossref
Crossref
Yaping Joyce Liao & Sachin Kedar. (2019) Should Antiviral/Anti-Varicella Zoster Virus Treatment Be Used in Patients With Giant Cell Arteritis?. Journal of Neuro-Ophthalmology 39:1, pages 134-141.
Crossref
Crossref
Sara Gale, Huong Trinh, Katie Tuckwell, Neil Collinson, John H. Stone, Khaled Sarsour, Jinglan Pei, Jennie Best, Christine Birchwood & Shalini V. Mohan. (2019) Adverse Events in Giant Cell Arteritis and Rheumatoid Arthritis Patient Populations: Analyses of Tocilizumab Clinical Trials and Claims Data. Rheumatology and Therapy 6:1, pages 77-88.
Crossref
Crossref
Edsel B. Ing, Gabriela Lahaie Luna, Christian Pagnoux, Philip A. Baer, Dani Wang, Etienne Benard-Seguin, Ishan Godra, Anita Godra, David G. Munoz, Kylen McReelis & Martin ten Hove. (2019) The incidence of giant cell arteritis in Ontario, Canada. Canadian Journal of Ophthalmology 54:1, pages 119-124.
Crossref
Crossref
Chetan Mukhtyar, Heidi Cate, Conor Graham, Peter Merry, Karen Mills, Aseema Misra & Colin Jones. (2019) Development of an evidence-based regimen of prednisolone to treat giant cell arteritis – the Norwich regimen. Rheumatology Advances in Practice 3:1.
Crossref
Crossref
Yaping Joyce Liao. (2018) Anti-Interleukin-6 Antibody as Treatment for Giant Cell Arteritis. Journal of Neuro-Ophthalmology 38:4, pages 558-560.
Crossref
Crossref
Sara Gale, Jessica C. Wilson, Jenny Chia, Huong Trinh, Katie Tuckwell, Neil Collinson, Sophie Dimonaco, Susan Jick, Christoph Meier, Shalini V. Mohan & Khaled Sarsour. (2018) Risk Associated with Cumulative Oral Glucocorticoid Use in Patients with Giant Cell Arteritis in Real-World Databases from the USA and UK. Rheumatology and Therapy 5:2, pages 327-340.
Crossref
Crossref
Achille Aouba, Solange Gonzalez Chiappe, Mireille Eb, Claire Delmas, Hubert de Boysson, Boris Bienvenu, Grégoire Rey & Alfred Mahr. (2018) Mortality causes and trends associated with giant cell arteritis: analysis of the French national death certificate database (1980–2011). Rheumatology 57:6, pages 1047-1055.
Crossref
Crossref
Alvise Berti & Christian Dejaco. (2018) Update on the epidemiology, risk factors, and outcomes of systemic vasculitides. Best Practice & Research Clinical Rheumatology 32:2, pages 271-294.
Crossref
Crossref
Matthew J Koster, Eric L Matteson & Kenneth J Warrington. (2018) Large-vessel giant cell arteritis: diagnosis, monitoring and management. Rheumatology 57:suppl_2, pages ii32-ii42.
Crossref
Crossref
L. K. Brekke, A. P. Diamantopoulos, B-T. Fevang, J. Aβmus, E. Esperø & C. G. Gjesdal. (2017) Incidence of giant cell arteritis in Western Norway 1972–2012: a retrospective cohort study. Arthritis Research & Therapy 19:1.
Crossref
Crossref
Alvise Berti, Divi Cornec, Cynthia S. Crowson, Ulrich Specks & Eric L. Matteson. (2017) The Epidemiology of Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis in Olmsted County, Minnesota. Arthritis & Rheumatology 69:12, pages 2338-2350.
Crossref
Crossref
Christian Dejaco, Elisabeth Brouwer, Justin C. Mason, Frank Buttgereit, Eric L. Matteson & Bhaskar Dasgupta. (2017) Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities. Nature Reviews Rheumatology 13:10, pages 578-592.
Crossref
Crossref
Cynthia S. Crowson & Eric L. Matteson. (2017) Contemporary prevalence estimates for giant cell arteritis and polymyalgia rheumatica, 2015. Seminars in Arthritis and Rheumatism 47:2, pages 253-256.
Crossref
Crossref
A. Mahr, A. Aouba, P. Richebé & S. Gonzalez-Chiappe. (2017) Épidémiologie et histoire naturelle de l’artérite à cellules géantes (Horton). La Revue de Médecine Interne 38:10, pages 663-669.
Crossref
Crossref
John J. Chen, Kenneth J. Warrington, James A. Garrity & Sashank Prasad. (2017) Is Routine Imaging of the Aorta Warranted in Patients With Giant Cell Arteritis?. Journal of Neuro-Ophthalmology 37:3, pages 314-319.
Crossref
Crossref
Rebecca L. Manno & Jason E. Liebowitz. 2017. Geriatrics for Specialists. Geriatrics for Specialists
227
242
.
Raashid Luqmani, Ellen Lee, Surjeet Singh, Mike Gillett, Wolfgang A Schmidt, Mike Bradburn, Bhaskar Dasgupta, Andreas P Diamantopoulos, Wulf Forrester-Barker, William Hamilton, Shauna Masters, Brendan McDonald, Eugene McNally, Colin Pease, Jennifer Piper, John Salmon, Allan Wailoo, Konrad Wolfe & Andrew Hutchings. (2016) The Role of Ultrasound Compared to Biopsy of Temporal Arteries in the Diagnosis and Treatment of Giant Cell Arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study. Health Technology Assessment 20:90, pages 1-238.
Crossref
Crossref
Dušica Pahor, Rajko Kavalar & Artur Pahor. (2016) Histologisch nachgewiesene Riesenzellarteriitis und SehverlustBiopsy-proven giant-cell arteritis and visual loss. Spektrum der Augenheilkunde 30:4-5, pages 169-174.
Crossref
Crossref
John J. Chen, Jacqueline A. Leavitt, Chengbo Fang, Cynthia S. Crowson, Eric L. Matteson & Kenneth J. Warrington. (2016) Evaluating the Incidence of Arteritic Ischemic Optic Neuropathy and Other Causes of Vision Loss from Giant Cell Arteritis. Ophthalmology 123:9, pages 1999-2003.
Crossref
Crossref
P. Elfving, O. Marjoniemi, H. Niinisalo, A. Kononoff, L. Arstila, E. Savolainen, J. Rutanen & O. Kaipiainen-Seppänen. (2016) Estimating the incidence of connective tissue diseases and vasculitides in a defined population in Northern Savo area in 2010. Rheumatology International 36:7, pages 917-924.
Crossref
Crossref
Matthew J. Koster, Kenneth J. Warrington & Tanaz A. Kermani. (2016) Update on the Epidemiology and Treatment of Giant Cell Arteritis. Current Treatment Options in Rheumatology 2:2, pages 138-152.
Crossref
Crossref
C. John MichetIIIIII, Cynthia S. Crowson, Sara J. Achenbach & Eric L. Matteson. (2015) The Detection of Rheumatic Disease through Hospital Diagnoses with Examples of Rheumatoid Arthritis and Giant Cell Arteritis: What Are We Missing?. The Journal of Rheumatology 42:11, pages 2071-2074.
Crossref
Crossref
Despina Michailidou, Tianyu Zhang, Pavlos Stamatis & Bernard Ng. (2021) Risk of Venous and Arterial Thromboembolism in Patients With Giant Cell Arteritis and/or Polymyalgia Rheumatica: A Veterans Health Administration Population-Based Study in the United States. SSRN Electronic Journal.
Crossref
Crossref